Brian Gladden Acquires 9,985 Shares of DENTSPLY SIRONA (NASDAQ:XRAY) Stock

Posted by Francis Steltz on Jun 17th, 2026

DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Free Report) Director Brian Gladden bought 9,985 shares of the firm’s stock in a transaction on Monday, June 15th. The shares were bought at an average cost of $10.02 per share, with a total value of $100,049.70. Following the purchase, the director directly owned 61,849 shares in the company, valued at approximately $619,726.98. This trade represents a 19.25% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

DENTSPLY SIRONA Trading Up 3.1%

Shares of NASDAQ:XRAY opened at $10.45 on Wednesday. The firm has a fifty day moving average of $10.93 and a two-hundred day moving average of $11.70. The firm has a market capitalization of $2.09 billion, a P/E ratio of -3.32, a price-to-earnings-growth ratio of 1.21 and a beta of 0.89. DENTSPLY SIRONA Inc. has a 12-month low of $9.40 and a 12-month high of $17.09. The company has a quick ratio of 0.98, a current ratio of 1.53 and a debt-to-equity ratio of 1.52.

DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) last issued its earnings results on Tuesday, May 5th. The medical instruments supplier reported $0.27 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.28 by ($0.01). The company had revenue of $880.00 million for the quarter, compared to analyst estimates of $841.80 million. DENTSPLY SIRONA had a negative net margin of 17.06% and a positive return on equity of 18.83%. The company’s quarterly revenue was up .1% on a year-over-year basis. During the same period last year, the business earned $0.43 EPS. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. On average, equities analysts expect that DENTSPLY SIRONA Inc. will post 1.42 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on XRAY. Mizuho decreased their target price on shares of DENTSPLY SIRONA from $16.00 to $14.00 and set a “neutral” rating for the company in a research note on Wednesday, May 6th. Robert W. Baird lifted their target price on shares of DENTSPLY SIRONA from $12.00 to $14.00 and gave the company a “neutral” rating in a research note on Friday, February 27th. Bank of America raised shares of DENTSPLY SIRONA from a “neutral” rating to a “buy” rating and lifted their target price for the company from $13.00 to $17.00 in a research note on Thursday, February 19th. Barrington Research lifted their target price on shares of DENTSPLY SIRONA from $14.00 to $17.00 and gave the company an “outperform” rating in a research note on Monday, March 2nd. Finally, UBS Group decreased their target price on shares of DENTSPLY SIRONA from $18.00 to $17.00 and set a “buy” rating for the company in a research note on Thursday, May 7th. Three research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $13.55.

View Our Latest Report on XRAY

Institutional Investors Weigh In On DENTSPLY SIRONA

Several institutional investors and hedge funds have recently modified their holdings of the business. Bank of America Corp DE lifted its stake in shares of DENTSPLY SIRONA by 18.3% in the 1st quarter. Bank of America Corp DE now owns 2,432,457 shares of the medical instruments supplier’s stock valued at $28,217,000 after purchasing an additional 375,994 shares during the last quarter. RBF Capital LLC lifted its stake in shares of DENTSPLY SIRONA by 2.5% in the 1st quarter. RBF Capital LLC now owns 205,000 shares of the medical instruments supplier’s stock valued at $2,378,000 after purchasing an additional 5,000 shares during the last quarter. Arkadios Wealth Advisors bought a new position in DENTSPLY SIRONA in the 1st quarter worth $870,000. California State Teachers Retirement System raised its holdings in DENTSPLY SIRONA by 24.0% in the 1st quarter. California State Teachers Retirement System now owns 232,031 shares of the medical instruments supplier’s stock worth $2,692,000 after acquiring an additional 44,918 shares during the period. Finally, Royal Bank of Canada raised its holdings in DENTSPLY SIRONA by 137.7% in the 1st quarter. Royal Bank of Canada now owns 256,701 shares of the medical instruments supplier’s stock worth $2,978,000 after acquiring an additional 148,702 shares during the period. Institutional investors and hedge funds own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

(Get Free Report)

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.